Steam-in-place system market seen reaching $2.97 billion by 2030

The Business Research Company says the steam-in-place system market will grow from $1.89 billion in 2025 to $2.07 billion in 2026, then reach $2.97 billion by 2030. Demand is being driven by pharmaceutical automation, biopharma expansion and food processing hygiene needs.

Why it matters: - Steam-in-place systems support sterile manufacturing in pharmaceuticals, biopharmaceuticals and food processing. - The market’s growth points to rising investment in contamination control, automation and compliance-heavy production. - The systems help manufacturers sterilize equipment, pipelines and vessels without disassembly, reducing downtime and contamination risk.

What happened: - The Business Research Company released a steam-in-place system market insights report on July 7, 2026. - The report says the market will rise from $1.89 billion in 2025 to $2.07 billion in 2026. - The report projects the market will reach $2.97 billion by 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The report includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future trend analysis. - The company offered a free sample and the full report.

The details: - Steam-in-place systems use pressurized steam to sterilize equipment, pipelines and vessels inside the system. - The process does not require disassembly. - The report cites strict pharmaceutical sterilization rules, contamination-free manufacturing requirements, biotechnology production growth, aseptic processing adoption and healthcare and medical device manufacturing expansion as key drivers for the 2025-2026 increase. - The report points to automated pharmaceutical plants, single-use and modular processing systems, energy-efficient sterilization, biologics and vaccine manufacturing, and validation and compliance frameworks as drivers through 2030. - The report identifies IoT-enabled real-time monitoring, AI-driven contamination risk prediction, cloud-based compliance tracking, smart automated sterilization systems and data-driven energy optimization as emerging trends. - The report says automation and integrated processing systems are a major catalyst because they require in-line sterilization with minimal human intervention. - In March 2026, the International Society for Pharmaceutical Engineering reported that more than 70% of pharmaceutical manufacturers had increased adoption of automation and digital integration in 2023 compared with previous years. - The report says the biopharmaceutical sector is expanding on higher biologics demand, increased R&D investment and approvals of novel drugs. - As of April 2023, the International Society for Pharmaceutical Engineering said biopharmaceutical companies and suppliers operated 1,580 production facilities across 48 U.S. states. - The report says food and beverage processing also supports demand because manufacturers need hygienic sterilization and food safety compliance. - In March 2024, the UK Department for Environment, Food & Rural Affairs said UK food and drink manufacturing generated more than £104 billion in turnover in 2024, about 20% of total UK manufacturing turnover, and employed more than 400,000 people. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

Between the lines: - The report suggests the market is shifting from a basic sterilization tool to a digitally monitored part of broader smart manufacturing systems. - The emphasis on energy efficiency and compliance tracking signals that cost control and regulation are becoming as important as hygiene. - North America’s lead and Asia-Pacific’s faster growth point to a mature base in one region and faster capacity buildout in another.

What's next: - The report expects growth to continue as pharmaceutical automation, biologics production and modular processing expand. - Adoption of connected monitoring and AI-based risk tools could further lift demand for newer SIP systems. - Expansion in food, beverage and medical manufacturing should keep sterilization upgrades on company capital plans.

The bottom line: - Steam-in-place systems are becoming a core utility for hygienic manufacturing, and the market’s next phase appears tied to automation, compliance and energy efficiency.